"
Team:USTC CHINA/Project/FutureWork
From 2013.igem.org
(Difference between revisions)
| Line 68: | Line 68: | ||
<p align="justify">Therefore, our future work includes：</br> | <p align="justify">Therefore, our future work includes：</br> | ||
| - | Explore the optimal conditions for Pht43 to express in WB800N to reduce the area of patches and enhance the average medicine production per unit area;</br> | + | 1.Explore the optimal conditions for Pht43 to express in WB800N to reduce the area of patches and enhance the average medicine production per unit area;</br> |
| - | Broaden the categories our vaccines, enhance the universality and accessibility of our transdermal immune methodology and find out the standard protocol for industrial production;</br> | + | 2.Broaden the categories our vaccines, enhance the universality and accessibility of our transdermal immune methodology and find out the standard protocol for industrial production;</br> |
| - | Cooperated with Professor WenLongping, the discoverer of TD1 to further better TD1 or search for other novel and excellent transdermal medium molecules;</br> | + | 3.Cooperated with Professor WenLongping, the discoverer of TD1 to further better TD1 or search for other novel and excellent transdermal medium molecules;</br> |
| - | Select sequential strong promoters as soon as possible to fulfill the automatic expression;</br> | + | 4.Select sequential strong promoters as soon as possible to fulfill the automatic expression;</br> |
| - | Better reporter system further to visualize every stage;</br> | + | 5.Better reporter system further to visualize every stage;</br> |
| - | Verify the practicability of our novel killing factor, instructed by our mathematical model.</br> | + | 6.Verify the practicability of our novel killing factor, instructed by our mathematical model.</br> |
</p> | </p> | ||
Revision as of 08:54, 28 October 2013
